Related Experiment Videos
The role of anxiety in predicting drinking behaviour
Tracy B Sloan1, John D Roache, Bankole A Johnson
1University of Texas Health Science Center, START Center, 7703 Floyd Curl Drive, Mail Stop 7792, San Antonio, TX 78229, USA.
Alcohol and Alcoholism (Oxford, Oxfordshire)
|June 20, 2003
Summary
Reduced anxiety levels during treatment predicted better drinking outcomes in alcoholics. This finding was independent of age of onset and ondansetron medication, highlighting anxiety management
Area of Science:
- Clinical Psychology
- Psychopharmacology
- Addiction Medicine
Background:
- Alcohol use disorder is a significant public health concern.
- Previous research indicates age of onset and ondansetron treatment influence drinking behaviors.
- The role of anxiety reduction in treatment outcomes requires further elucidation.
Purpose of the Study:
- To determine if reduced anxiety predicts improved drinking outcomes in alcoholics.
- To assess if anxiety reduction's predictive power extends beyond age of onset and ondansetron treatment.
- To investigate the impact of anxiety changes on end-state drinking behavior.
Main Methods:
- A 2x4 factorial randomized clinical trial involving early and late-onset alcoholics.
- Participants received placebo or varying doses of ondansetron with weekly group cognitive behavioral therapy.
- Weighted least squares regression analyzed the influence of ondansetron dose, age of onset, pre-treatment drinking, and anxiety on drinking outcomes.
Main Results:
- Changes in anxiety level significantly predicted end-state drinking behavior.
- Decreased anxiety during treatment correlated with fewer drinks per day at the final visit.
- Anxiety reduction accounted for a significant proportion of variance in drinking outcomes.
Conclusions:
- Reduced anxiety is a significant predictor of improved drinking outcomes in alcoholics.
- Anxiety management may be a crucial therapeutic target in alcohol use disorder treatment.
- These findings add to the understanding of factors influencing treatment success beyond medication and onset age.